Bodycote profit advances in first half, streamlining plan pushes ahead
(Alliance News) - Bodycote PLC on Tuesday posted higher profit in the first half of 2026 and reaffirmed its potential heading into the second part of the year, as it continued to progress its streamlining plan.
The Macclesfield, England-based provider of heat treatment and specialist metallurgical technology services reported pretax profit of GBP41.2 million in the six months that ended June 30, up from GBP36.6 million year earlier.
Revenue advanced 3.3% to GBP381.2 million from GBP369.0 million, with core revenue, which excludes non-core sites that are part of the company's 'optimise' programme, rising by 9.6% on-year to GBP372.0 million.
This programme was introduced in 2024 and framed as a way to improve the business by "closing sites, that were utilising older less efficient, and more carbon intensive technologies". Bodycote extended the programme in July last year and at the end of last month, said it had announced all planned closures, most of which had already completed.
The board has approved an interim dividend of 7.2 pence per share, which represents an increase of 4.3% from 6.9p the previous year.
Bodycoted noted "strong growth" in Aerospace & Defence, Industrial Gas Turbines, Medical and Semiconductors, which was "partly offset by continued weakness in Automotive, particularly in Europe".
Looking ahead to all of 2026, the company left its guidance unchanged, targeting organic revenue growth and margin improvement, thanks in part to the 'optimise' programme, and in spite of an anticipated uptick in variable pay and growth investment costs.
In the second half, Bodycote is looking to make further strategic progress, though Chief Executive Jim Fairbairn cautioned that the pace of revenue growth is likely to moderate, "reflecting prior-year comparators". Bodycote remains confident in its medium-term goals.
"We progressed well in the first half and have achieved results in line with our expectations. Organic growth was supported by strong demand across our target end markets, partly offset by the ongoing structural weakness in Western European Automotive," noted CEO Fairbairn.
"We continue to execute on our 'optimise, perform and grow' strategy. In light of the success of the 'optimise' programme to-date, as well as continued challenges in some of our Automotive and Industrial regional markets, we are exploring the potential to expand the programme's scope. In 'perform', we have rolled-out more advanced operational excellence tools, starting at four key 'lighthouse sites'. In 'grow', the Spectrum acquisition has integrated well. We are continuing to progress with both organic investments and further M&A opportunities.
Our full year expectations are unchanged, albeit we are mindful of the current geopolitical and macroeconomic environment."
Bodycote shares rose 1.0% to 695.84p each on Tuesday morning in London.
By Holly Munks, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2026 Alliance News Ltd. All Rights Reserved.
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy for the Long-Term While They’re Still Undervalued
6 ETFs To Diversify Away From AI
Why This Vanguard ETF Is One of the Best
The Best AI Stocks to Buy Now